GGrantIndex
← Search

A RANDOMIZED, MULTICENTER TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF STAPHYLOCOCCUS AUREUS TOXOIDS, RAT AND RLUKS-PV, IN HEALTHY VOLUNTEERS

$471,917FY2009Department of the ArmyDOD

Nabi Biopharmaceuticals, Rockville MD

Investigators

View source on USAspending →
A RANDOMIZED, MULTICENTER TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF STAPHYLOCOCCUS AUREUS TOXOIDS, RAT AND RLUKS-PV, IN HEALTHY VOLUNTEERS · GrantIndex